Clinical Trials Directory

Trials / Unknown

UnknownNCT06141213

The Relationship Between Fetal Membrane Thickness and Fetal Chromosomal Aneuploidies

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Tianjin Central Hospital of Gynecology Obstetrics · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This observational study aims to recruit pregnant women between 18 to 24 weeks of gestation to investigate the relationship between amniotic membrane thickness and fetal chromosomal abnormalities. The primary objectives are to establish whether a correlation exists between the measured thickness of the amniotic membrane and the presence of chromosomal abnormalities in the fetus, and to determine a cutoff value for amniotic membrane thickness that could indicate an increased risk of such abnormalities. Additionally, the study seeks to assess whether the inclusion of amniotic membrane thickness as a biomarker can enhance the detection rate of non-invasive prenatal testing (NIPT) and nuchal translucency (NT) for chromosomal abnormalities.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTUltrasound screeningUltrasound screening for fetal membrane thickness at 18-24 weeks of pregnancy.

Timeline

Start date
2021-10-01
Primary completion
2023-12-31
Completion
2024-08-31
First posted
2023-11-21
Last updated
2023-11-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06141213. Inclusion in this directory is not an endorsement.